Hormonal
Hyperinsulinemia alone inhibits whole-body protein synthesis and degradation by lowering plasma amino acid concentrations, whereas maintaining basal or elevated amino acid levels allows insulin to stimulate protein synthesis and suppress degradation.
To maximize muscle protein synthesis, you cannot rely on insulin alone. If you consume carbohydrates that spike insulin without adequate protein, your body may actually reduce protein synthesis because insulin lowers circulating amino acids. Ensure you consume sufficient protein alongside carbohydrates to maintain plasma amino acid levels, allowing insulin to effectively stimulate muscle building.
We conclude that: (a) hyperinsulinemia alone decreases plasma leucine concentration and inhibits endogenous leucine flux (protein breakdown), leucine oxidation, and nonoxidative leucine disposal (protein synthesis); (b) hyperaminoacidemia, whether in combination with hyperinsulinemia or with maintained basal insulin levels decreases endogenous leucine flux and stimulates both leucine oxidation and nonoxidative leucine disposal.
Why this rating
Controlled clinical study with rigorous methodology (euglycemic clamp, isotope tracers), though small sample size (n=15).
Source
Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis.
Pietro Castellino et al. · Journal of Clinical Investigation · 1987
DOI 10.1172/jci113272
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →